You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
科美診斷(688468.SH)獲得2項發明專利
格隆匯 05-19 16:07

格隆匯5月19日丨科美診斷(688468.SH)公佈,公司於近日收到了2項國家知識產權局頒發的發明證書。專利名稱分別為“一種均相免疫檢測方法及其應用”、“一種無基質效應的均相免疫檢測試劑盒及其分析方法”。

一種均相免疫檢測方法及其應用:該專利保護的技術方案系公司自主研發,其是在至少兩個檢測區域中判斷是否存在含有待測抗原和/或待測抗體的複合物,建立起了一種高效、可靠的用於抗原抗體聯合檢測的均相免疫檢測方法,解決了均相免疫分析方法中抗原抗體聯合檢測時不能區分陽性結果是抗體陽性或抗原陽性的問題。

一種無基質效應的均相免疫檢測試劑盒及其分析方法:該專利保護的技術方案系公司自主研發,提出了一種新型均相光激化學發光檢測試劑盒及其分析方法,其通過在已知抗原(與被分析抗體結合的抗原)與被分析抗體結合後增加磁場分離環節,能有效去除非特異性抗體和其他干擾物,從而消除非特異性抗體和其他干擾物的影響。利用該試劑盒分析待檢樣本中抗原或抗體的方法能夠消除均相免疫檢測中的基質效應,解決了光激化學發光技術領域中長期以來無法使用間接法測定抗體的重要技術難題。

公司表示,上述發明專利權的取得不會對公司目前的經營狀況產生重大的影響,但有利於進一步完善公司的知識產權體系,充分發揮公司的知識產權優勢,促進公司技術創新及產品結構的不斷豐富,從而提升公司的核心競爭力。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account